AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 165 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,318,000 | +451.5% | 46,593 | +331.9% | 0.01% | +600.0% |
| Q2 2022 | $239,000 | -89.2% | 10,787 | -83.9% | 0.00% | -95.2% |
| Q4 2021 | $2,203,000 | +203.9% | 67,029 | +326.8% | 0.02% | +133.3% |
| Q3 2021 | $725,000 | +309.6% | 15,706 | +388.8% | 0.01% | +350.0% |
| Q2 2021 | $177,000 | -95.0% | 3,213 | -95.4% | 0.00% | -95.7% |
| Q1 2021 | $3,569,000 | +8.2% | 69,116 | -9.2% | 0.05% | +2.2% |
| Q4 2020 | $3,299,000 | -35.6% | 76,133 | -48.0% | 0.04% | -40.8% |
| Q3 2020 | $5,120,000 | +2315.1% | 146,272 | +3592.8% | 0.08% | +1800.0% |
| Q2 2020 | $212,000 | -51.9% | 3,961 | -68.1% | 0.00% | -66.7% |
| Q1 2020 | $441,000 | -76.4% | 12,417 | -78.5% | 0.01% | -67.6% |
| Q3 2019 | $1,869,000 | +90.9% | 57,675 | +193.7% | 0.04% | +105.6% |
| Q2 2019 | $979,000 | +8.2% | 19,636 | +0.1% | 0.02% | -58.1% |
| Q4 2018 | $905,000 | +3132.1% | 19,626 | +5233.2% | 0.04% | +2050.0% |
| Q3 2018 | $28,000 | -71.1% | 368 | -68.0% | 0.00% | -60.0% |
| Q2 2018 | $97,000 | +506.2% | 1,150 | +475.0% | 0.01% | +400.0% |
| Q1 2018 | $16,000 | +166.7% | 200 | +100.0% | 0.00% | – |
| Q4 2017 | $6,000 | -96.2% | 100 | -95.8% | 0.00% | -100.0% |
| Q3 2017 | $160,000 | -9.1% | 2,391 | -30.1% | 0.01% | -18.2% |
| Q2 2017 | $176,000 | +877.8% | 3,423 | +1041.0% | 0.01% | +1000.0% |
| Q1 2017 | $18,000 | -35.7% | 300 | -55.0% | 0.00% | -50.0% |
| Q4 2016 | $28,000 | -83.3% | 666 | -79.1% | 0.00% | -81.8% |
| Q3 2016 | $168,000 | -64.0% | 3,179 | -71.5% | 0.01% | -59.3% |
| Q2 2016 | $467,000 | +138.3% | 11,148 | +130.9% | 0.03% | +145.5% |
| Q1 2016 | $196,000 | -16.9% | 4,829 | +25.7% | 0.01% | -21.4% |
| Q3 2014 | $236,000 | – | 3,842 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Ventures 2007 General Partner LLC | 1,930,369 | $118,428,000 | 83.56% |
| Third Rock Ventures, LLC | 3,070,090 | $188,350,000 | 21.97% |
| Opaleye Management Inc. | 113,500 | $6,963,225,000 | 5.43% |
| BB BIOTECH AG | 1,890,521 | $115,983,000 | 4.72% |
| Eventide Asset Management | 431,600 | $26,479,000 | 3.70% |
| Atika Capital Management LLC | 54,000 | $3,313,000 | 2.55% |
| Cormorant Asset Management, LP | 100,000 | $6,135,000 | 1.26% |
| BRIDGER MANAGEMENT, LLC | 220,099 | $13,503,000 | 0.92% |
| Ghost Tree Capital, LLC | 20,000 | $1,227,000 | 0.67% |
| HAMILTON LANE ADVISORS LLC | 27,544 | $1,690,000 | 0.55% |